QR Code

Immunopersistence of one or two doses of an Escherichia coli produced bivalent HPV vaccine

Abstract Data on the immunopersistence of one- or two-dose regimens of HPV vaccine in women aged 18–45 remains scarce. During 5.5-year follow-up of a Phase 3 clinical trial of Cecolin® (ClinicalTrials.gov, NCT01735006), blood samples were collected at day 0, month 7 and annually thereafter for neutr...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Mengjun Liao, Jiali Quan, Kongxin Zhu, Xiaowen Hu, Shudan Shen, Jianhua Xu, Chu Nie, Weizhuo Xu, Hexuan Jiang, Xianliang Wu, Yanqin Zhong, Yuhang Peng, Shihui Cai, Jie Chen, Chengzong Zhang, Bizhen Lin, Yingying Su, Shoujie Huang, Qi Chen, Ting Wu, Jun Zhang, Ningshao Xia
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Nature Portfolio 2025-12-01
Rangatū:npj Vaccines
Urunga tuihono:https://doi.org/10.1038/s41541-025-01335-2
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite